Migraine Trial, Recruiting (NCT06785129)

Migraine Trial, Recruiting NCT06785129 Sponsor: Washington University School of Medicine Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT06785129 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with endometriosis, migraines, or both
OR you are a healthy volunteer with no history of long-term (chronic) pain
You are between 12 and 45 years old
You were assigned female sex at birth

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a type of non-cancerous brain tumour called a prolactinoma
You have been diagnosed with a psychiatric (mental health), neurological (brain/nervous system), hormonal, or developmental condition, or you take medications for any of these conditions
You currently take dopamine agonist medications (used for conditions like Parkinson's disease or certain hormonal problems) or SSRI medications (a common type of antidepressant)
If you are aged 12–17, a parent or legal guardian must be willing to sign the consent forms and complete health surveys about you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hadas Nahman-Averbuch, PhD, Washington University School of Medicine

Phone: 314-273-6194

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06785129

Sponsor: Washington University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: 314-273-6194

More information: https://clinicaltrials.gov/study/NCT06785129

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with endometriosis, migraines, or both
OR you are a healthy volunteer with no history of long-term (chronic) pain
You are between 12 and 45 years old
You were assigned female sex at birth

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a type of non-cancerous brain tumour called a prolactinoma
You have been diagnosed with a psychiatric (mental health), neurological (brain/nervous system), hormonal, or developmental condition, or you take medications for any of these conditions
You currently take dopamine agonist medications (used for conditions like Parkinson's disease or certain hormonal problems) or SSRI medications (a common type of antidepressant)
If you are aged 12–17, a parent or legal guardian must be willing to sign the consent forms and complete health surveys about you

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

12 February 2025

Est. completion

1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Conditioned pain modulation (CPM) response; Sex Hormones

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov